About Us
We cover the science most people are still sleeping on.
Peptide Next is the independent media brand for peptide science, biohacking, and longevity research — written for people who want the real information, not the sales pitch.
The peptide space is moving fast.
New compounds. New studies. New protocols. And almost no trustworthy place to make sense of all of it.
Most of what exists online is either locked behind paywalls in academic journals, buried in Reddit threads, or dressed up as "education" by brands with something to sell. The credible middle ground — rigorous but readable, scientific but accessible — has been empty for too long.
That's why Peptide Next exists.
We cover peptides the way good journalism covers anything important: with sourced reporting, clear language, and no financial interest in what you decide to do with the information. No supplements to sell. No affiliate-driven stack recommendations disguised as reviews. Just the science, translated.
WHAT WE COVER
Compound Deep Dives Full profiles on the peptides people are actually using — mechanism of action, dosing protocols, half-life, stacking considerations, safety data, and legal status. The reference content you'll come back to.
Research Translation New studies, clinical trials, and pre-prints broken down into plain language. We read the paper so you don't have to — and we tell you exactly what it means and what it doesn't.
Biohacking & Culture The protocols, the practitioners, the experiments. The humans pushing the edges of performance and longevity and what we can learn from watching them do it.
Regulatory Watch FDA actions, DEA scheduling updates, compounding pharmacy rules, grey market dynamics. The policy layer of the peptide world moves constantly — we keep eyes on it so you don't miss what matters.
New Release Radar Emerging compounds, novel formulations, and conference previews. When something new enters the conversation, we're the first place it gets covered properly.
OUR STANDARDS
Every claim is sourced. Every study is linked. Every piece of speculation is labeled as such.
We don't use the words "cure," "treat," or "heal." We don't make before-and-after promises. We don't publish content we wouldn't stand behind in front of a researcher.
When we get something wrong, we correct it — visibly, promptly, and without burying the correction.
This is informational content, not medical advice. Always consult a licensed healthcare provider before starting any peptide protocol. We mean that, and we'll keep saying it.
WHO THIS IS FOR
If you're already using peptides and want deeper, more reliable information than you're finding elsewhere — this is for you.
If you're new to the space and trying to figure out what's real and what's hype — this is for you.
If you're a clinician, researcher, or practitioner looking for a resource you can actually reference — this is for you.
If you want to be sold something — this is not for you.
The science is moving fast. We'll make sure you keep up.
Get the Peptide Next briefing — research, compound updates, and regulatory news delivered weekly. Free to start. No spam. Unsubscribe anytime.